DAHRT Biocare publishes article on the science behind Ceventrix™

CEVENTRIX ™ is the first product in our portfolio and is based on more than 15 years of scientific research on the importance of gastrointestinal health in MS. The research includes changes in gastrointestinal health, the effect on the immune system, and how these conditions together affect the disease.

To see this in a larger context, and test the rationale behind the use of CEVENTRIX ™ in the scientific community, DAHRT Biocare has published a peer-reviewed review article in “Frontiers of Immunology”, an internationally recognized journal. The article describes the scientific background for the use of CEVENTRIX ™ in MS, and discusses relevant findings in the regulation of immunological conditions. To date, the article has been viewed more than 1,000 times.

The article is authored in collaboration with Professor Philip Calder from the University of Southampton in England. We are grateful for his contribution and support for the work. Professor Calder is a highly regarded expert in nutrition science, and one of the most published nutrition researchers of our time.

The article has been reviewed by four peers who have all reviewed the content critically. Their name and affiliation are stated in the article to ensure full transparency. They are of the highest caliber and include researchers from Sweden, Italy and Spain.

The article is available free of charge and you are given access by following this link: The Nutritional management of Multiple Sclerosis with propionate